Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis

Figure 2

Efficacy outcomes according to treatment (empagliflozin versus placebo); the thick line indicates the median, the box indicates the interquartile range, and the whiskers include all points within the range of 1.5x the interquartile range. (a) Trajectory of glucosuria (note that y-axis is on log scale). (b) Trajectory of urinary excretion. (c) Trajectory of serum sodium. (d) Area under the curve (timepoints 2 to 8) for serum sodium concentration.

(a)

(b)

(c)

(d)